Updates on Antibiotic Regimens in Acute Cholecystitis

Area of Science:

• Gastroenterology
• Surgical Infections
• Antimicrobial Therapy

Background:

• Acute cholecystitis is a frequent surgical condition with significant mortality, especially when complicated by bacteremia.
• Bile bacterial colonization occurs in 35-60% of patients, with common pathogens including E. coli and Klebsiella spp.
• Standard treatment involves early laparoscopic cholecystectomy, with antibiotics crucial for managing inflammation and preventing complications.

Purpose of the Study:

• To emphasize the critical role of antibiotic therapy in managing acute cholecystitis.
• To highlight factors influencing antibiotic selection and the importance of tailoring therapy based on bile cultures.
• To promote antibiotic stewardship for optimal treatment of bile-related infections.

Main Methods:

• Review of current literature on acute cholecystitis and antimicrobial treatment strategies.
• Analysis of common bacterial pathogens and their resistance patterns in bile infections.
• Discussion of factors influencing empirical and targeted antibiotic selection.

Main Results:

• Antibiotic therapy is essential for preventing surgical complications and managing systemic inflammation in moderate to severe acute cholecystitis.
• Effective treatment requires consideration of infection source, severity, drug penetration, and local resistance patterns.
• Modification of therapy based on bile culture results is vital for severe cases.

Conclusions:

• Early empirical antimicrobial therapy combined with source control is fundamental for successful acute cholecystitis treatment.
• Antibiotic stewardship, including appropriate selection and duration of therapy, is key to managing bile-related infections.
• Adherence to evidence-based antibiotic guidelines is crucial for good clinical practice in acute cholecystitis management.